APA (7th ed.) Citation

D, R., WM, M., R, K., A, S., & BD, B. (2011). Changes in erythropoiesis-stimulating agent (ESA) dosing and haemoglobin levels in US non-dialysis chronic kidney disease patients between 2005 and 2009. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 26(5), 1583. https://doi.org/10.1093/ndt/gfq573

Chicago Style (17th ed.) Citation

D, Regidor, McClellan WM, Kewalramani R, Sharma A, and Bradbury BD. "Changes in Erythropoiesis-stimulating Agent (ESA) Dosing and Haemoglobin Levels in US Non-dialysis Chronic Kidney Disease Patients Between 2005 and 2009." Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association 26, no. 5 (2011): 1583. https://doi.org/10.1093/ndt/gfq573.

MLA (9th ed.) Citation

D, Regidor, et al. "Changes in Erythropoiesis-stimulating Agent (ESA) Dosing and Haemoglobin Levels in US Non-dialysis Chronic Kidney Disease Patients Between 2005 and 2009." Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association, vol. 26, no. 5, 2011, p. 1583, https://doi.org/10.1093/ndt/gfq573.